Knowledge Hub

Pharmaceutical Market Report On Cancer Genetics Inc (CGIX) - Product Pipeline Analysis, 2016 Update

Press Release   •   Feb 02, 2017 04:54 EST

Cancer Genetics Inc (CGI) is a pharmaceutical company that provides diagnostics products and services in oncology areas. The company offers products such as CGH Microarrays, Next-Generation Sequencing and DNA-FISH Probes. Its oncology tests and laboratory services offer critical genomic information to healthcare professionals, biopharma companies, and cancer centers. CGIs clinical services include expand DX, test menu, complete program, and summation report. The company offers a range of pharmacogenomics testing services for clinical oncologists, cancer centers, and research institutions, and for biotech and biopharma customers engaged in clinical trials. It works in research collaboration with cancer centers to develop and validate proprietary tests. CGI is headquartered in Rutherford, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

View Report @ http://www.marketresearchreports.biz/analysis/948180

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Cancer Genetics Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Get Sample Copy Of This Report @

http://www.marketresearchreports.biz/sample/sample/948180

Table of Contents

List of Tables 4

List of Figures 5

Cancer Genetics Inc Company Overview 6

Cancer Genetics Inc Company Snapshot 6

Cancer Genetics Inc Pipeline Products and Clinical Trials Overview 7

Cancer Genetics Inc Pipeline Analysis Overview 10

Key Facts 10

Cancer Genetics Inc - Major Products and Services 11

Cancer Genetics Inc Pipeline Products by Development Stage 12

Cancer Genetics Inc Pipeline Products Overview 14

Diagnostic Panel - Myelodysplastic Syndrome 14

Diagnostic Panel - Myelodysplastic Syndrome Product Overview 14

FHACT Test - Head and Neck Cancer 15

FHACT Test - Head and Neck Cancer Product Overview 15

FReCaD Renal Cancer Test 16

FReCaD Renal Cancer Test Product Overview 16

LeukA - Leukemia 17

LeukA - Leukemia Product Overview 17

MatBA Diagnostic Test - Marginal Zone Lymphoma 18

MatBA Diagnostic Test - Marginal Zone Lymphoma Product Overview 18

MatBA Diagnostic Test - Multiple Myeloma 19

MatBA Diagnostic Test - Multiple Myeloma Product Overview 19

Next-Gen DNA Sequencing Assay - Follicular Lymphoma 20

Next-Gen DNA Sequencing Assay - Follicular Lymphoma Product Overview 20

Next-Generation Sequencing Based Test - Lung Cancer 21

Next-Generation Sequencing Based Test - Lung Cancer Product Overview 21

UGenRA - Cervix 22

UGenRA - Cervix Product Overview 22

UGenRA - Endometrium 23

UGenRA - Endometrium Product Overview 23

UGenRA - Ovarian Cancer 24

UGenRA - Ovarian Cancer Product Overview 24

UroGenRA - Bladder 25

UroGenRA - Bladder Product Overview 25

UroGenRA - Prostate 26

UroGenRA - Prostate Product Overview 26

Cancer Genetics Inc - Key Competitors 27

Cancer Genetics Inc - Key Employees 28

Cancer Genetics Inc - Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 31

Read our latest Press Release at http://www.marketresearchreports.biz/pressreleases

 

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.